Lymphatica Medtech Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 18

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $19.8M

  • Investors
  • 17

Lymphatica Medtech General Information

Description

Developer of implantable devices designed to re-establish lymphatic circulation in individuals affected by lymphedema. The company produces the first active implantable lymphatic bypass, consisting of an implanted magnetically controlled micropump and catheters that internally drain the lymphatic fluid from multiple points in the affected limb, enabling patients to have an effective remedy for lymphedema.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Route de la Maladière 58
  • Vaud
  • 1022 Chavannes-près-Renens
  • Switzerland
Primary Industry
Therapeutic Devices
Other Industries
Other Healthcare Technology Systems
Corporate Office
  • Route de la Maladière 58
  • Vaud
  • 1022 Chavannes-près-Renens
  • Switzerland

Lymphatica Medtech Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Lymphatica Medtech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
23. Later Stage VC (Series B) 08-Oct-2024 $19.8M Completed Generating Revenue
22. Debt - General 15-Jun-2023 Completed Generating Revenue
21. Accelerator/Incubator 28-Apr-2023 Completed Generating Revenue
20. Accelerator/Incubator 01-Jan-2023 Completed Generating Revenue
19. Accelerator/Incubator 25-Apr-2022 Completed Product Development
18. Later Stage VC 13-Apr-2022 Completed Product Development
17. Accelerator/Incubator 09-Jun-2021 Completed Product Development
16. Early Stage VC (Series A) 09-Nov-2020 Completed Product Development
15. Early Stage VC 10-Mar-2020 $160K $555K Completed Product Development
14. Grant 01-Sep-2019 $2M $395K Completed Product Development
To view Lymphatica Medtech’s complete valuation and funding history, request access »

Lymphatica Medtech Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Ordinary
To view Lymphatica Medtech’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Lymphatica Medtech Patents

Lymphatica Medtech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2024400104-A1 Systems and methods for a bodily fluid drainage system Pending 13-Dec-2023
EP-4823660-A1 Systems and methods for a bodily fluid drainage system Pending 13-Dec-2023
US-12138378-B1 Systems and methods for a bodily fluid drainage system Active 13-Dec-2023
US-12280228-B1 Systems and methods for a bodily fluid drainage system Active 13-Dec-2023
US-20250235589-A1 Systems and methods for a bodily fluid drainage system Pending 13-Dec-2023 A61M27/002
To view Lymphatica Medtech’s complete patent history, request access »

Lymphatica Medtech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Lymphatica Medtech Investors (17)

Investor Name Investor Type Holding Investor Since Participating Rounds
CDP Venture Capital (Rome) Venture Capital Minority
Club degli investitori Angel Group Minority
OCCIDENT () Family Office Minority
Panakes Partners Venture Capital Minority
TechWald Holding Holding Company Minority
You’re viewing 5 of 17 investors. Get the full list »

Lymphatica Medtech FAQs

  • When was Lymphatica Medtech founded?

    Lymphatica Medtech was founded in 2016.

  • Where is Lymphatica Medtech headquartered?

    Lymphatica Medtech is headquartered in Chavannes-près-Renens, Switzerland.

  • What is the size of Lymphatica Medtech?

    Lymphatica Medtech has 18 total employees.

  • What industry is Lymphatica Medtech in?

    Lymphatica Medtech’s primary industry is Therapeutic Devices.

  • Is Lymphatica Medtech a private or public company?

    Lymphatica Medtech is a Private company.

  • What is the current valuation of Lymphatica Medtech?

    The current valuation of Lymphatica Medtech is .

  • What is Lymphatica Medtech’s current revenue?

    The current revenue for Lymphatica Medtech is .

  • How much funding has Lymphatica Medtech raised over time?

    Lymphatica Medtech has raised $37M.

  • Who are Lymphatica Medtech’s investors?

    CDP Venture Capital (Rome), Club degli investitori, OCCIDENT (), Panakes Partners, and TechWald Holding are 5 of 17 investors who have invested in Lymphatica Medtech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process